|
|
Registry of biomedical companies:
[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 450 active entries
Rue Bois Saint Jean 5
Seraing, 4102
Belgium
Phone: +32-4-372-7400 Fax: +32-4-372-7500 Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Description:
Eurogentec GroupEurogentec SA is a contract manufacturing organization providing custom products and services to researchers in the diagnostic and biopharmaceutical sciences. The company operates under ISO 9001, ISO 13485 and injectable GMP quality systems. The close collaboration between Eurogentec’s two business units is Eurogentec’s unique capability to fully support drug development projects from early R&D to commercial phases.
• The “Genomics & Proteomics” business unit provides custom oligonucleotide, peptide, RT-PCR products, customized polyclonal and monoclonal antibody production and a range of kits and consumables in a variety of scales for basic research to commercial in vitro diagnostics applications.
• The “Biologics” business unit offers contract process development and GMP manufacturing of recombinant proteins, plasmids, biosimilars and vaccines for clinical trials and commercial uses. Eurogentec received its GMP accreditation in 1994 and since then has developed over 80 different GMP processes for clients around the world. Working solely in microbes (E. coli, P. pastoris, etc) we are experts in protein refolding, periplasmic expression, and protein expression using pichia secretion systems. Technological offerings include high yielding fermentation processes for proteins and plasmids, off-patent pichia expression systems, and protein modifications by chemical couplings (PEG, peptide-protein, etc).
Headquartered in Belgium and with strategically located subsidiaries worldwide, the Eurogentec Group employs a team of 325 people. Learn more at www.eurogentec.com
Selected Categories:
Last update of this entry: July 10, 2013
|